Metamark announces nationwide availability of ProMark™ prostate cancer test, first-of-its-kind protein-based prognostic test

Metamark has announced the nationwide availability of ProMark™, the first-of-its-kind protein-based biopsy test designed to improve the accuracy of prognosis for men diagnosed with prostate...